← back to search

Antonella Brunello

Hospital Universitario Fundación Jiménez Díaz · IT
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Sarcoma Diagnosis and Treatment, Frailty in Older Adults, Vascular Tumors and Angiosarcomas, and Cardiac tumors and thrombi.
h-index
32
citations
3,744
works
291
NIH funding
primary concept
Medicine
email

Recent publications

How Should Primary Pulmonary Sarcoma be Staged? Results of an International Multicentre Analysis
European Journal of Cardio-Thoracic Surgery 2026cited by 0position: middledoi
Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group network
ESMO Open 2026cited by 0position: middledoi
Patient-reported outcomes (PROs) in clinical trials and in clinical practice: report from the XXI national conference of the Italian Association of Medical Oncology (AIOM)
BMJ Oncology 2025cited by 10position: middledoi
2025 National Guidelines on the Mediterranean Diet: Executive Summary of a Joint Report by Italian Scientific Societies and the National Institute of Health Task Force on Clinical Practice Guidelines
Nutrition Reviews 2025cited by 6position: middledoi
Beyond Treatment Decisions: The Predictive Value of Comprehensive Geriatric Assessment in Older Cancer Patients
Cancers 2025cited by 6position: lastdoi
Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma Group
Critical Reviews in Oncology/Hematology 2025cited by 3position: middledoi
Outcome of patients with curative-intent treatment for primary pulmonary sarcoma: Results from an international multicenter retrospective study
JTCVS Open 2025cited by 1position: middledoi
Performance and clinical utility of two targeted multigene panels for GIST molecular characterization
Scientific Reports 2025cited by 1position: middledoi
Outcome of Patients with Curative-Intent Treatment for Primary Pulmonary Sarcoma: Results of an International Multicenter Database
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie 2025cited by 0position: middledoi
How should Primary Pulmonary Sarcoma be staged? Results of an International Multicenter Database
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie 2025cited by 0position: middledoi
Trabectedin–olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma Group
Annals of Oncology 2025cited by 0position: middledoi
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet 2024cited by 64position: middledoi
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)
Journal of Clinical Oncology 2024cited by 22position: middledoi
Kaposi’s Sarcoma: Evaluation of Clinical Features, Treatment Outcomes, and Prognosis in a Single-Center Retrospective Case Series
Cancers 2024cited by 14position: middledoi
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group
Cancer Treatment Reviews 2024cited by 13position: middledoi
Primary vascular tumors of bone: A comprehensive literature review on classification, diagnosis and treatment
Critical Reviews in Oncology/Hematology 2024cited by 10position: lastdoi
Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group
ESMO Open 2024cited by 8position: middledoi
International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms
The American Journal of Surgical Pathology 2024cited by 4position: middledoi
Proximal and Classic Epithelioid Sarcomas are Distinct Molecular Entities Defined by MYC/GATA3 and SOX17/Endothelial Markers, Respectively
Modern Pathology 2024cited by 3position: middledoi
The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity
PLoS ONE 2024cited by 3position: middledoi
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)
European Journal of Cancer 2023cited by 39position: middledoi
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence
JAMA Network Open 2023cited by 5position: middledoi
<scp>CINSARC</scp> in high‐risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the <scp>ISG‐STS</scp> 1001 study
Cancer Medicine 2022cited by 25position: middledoi
Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analyses
Breast Cancer Research and Treatment 2022cited by 17position: middledoi
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis
Frontiers in Oncology 2022cited by 7position: middledoi
Trabectedin in advanced retroperitoneal well differentiated/dedifferentiated liposarcoma and leiomyosarcoma (TRAVELL): Results of a phase 2 study from Italian sarcoma group (ISG).
Journal of Clinical Oncology 2022cited by 2position: middledoi
Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial
Cancer 2021cited by 100position: middledoi
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature
Cancer Medicine 2021cited by 50position: middledoi
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study
Clinical Cancer Research 2021cited by 43position: middledoi
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group
Cancers 2021cited by 21position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bruno Vincenzi · Università Campus Bio-Medico19 papers (2017–2025)Angelo Paolo Dei Tos · University of Padua12 papers (2018–2025)Giovanni Grignani · Hospital Universitario Fundación Jiménez Díaz12 papers (2017–2025) · 10 papers (2018–2025)Silvia Gasperoni · European Society for Medical Oncology9 papers (2018–2026)Silvia Stacchiotti · Dana-Farber Cancer Institute9 papers (2017–2025)Paolo G. Casali · Fondazione IRCCS Istituto Nazionale dei Tumori7 papers (2017–2022)Anna Maria Frezza · Fondazione IRCCS Istituto Nazionale dei Tumori7 papers (2017–2022)Giacomo Giulio Baldi · Novartis (Switzerland)7 papers (2019–2025) · 6 papers (2018–2025)Maria A. Pantaleo · Instituto Nazionale Tumori Regina Elena6 papers (2021–2025)Andrea Napolitano · Università Campus Bio-Medico5 papers (2018–2021)Elena Fumagalli · Fondazione IRCCS Istituto Nazionale dei Tumori5 papers (2020–2025) · 5 papers (2020–2025)Alessandro Gronchi · Dana-Farber Cancer Institute5 papers (2019–2022)Marta Sbaraglia · University of Padua5 papers (2020–2025)Stéphane Collaud · Kliniken der Stadt Köln4 papers (2025–2026)Gloria Marquina · University of Lausanne4 papers (2025–2026)Luigi Cerbone · Azienda Sanitaria Locale Alessandria4 papers (2025–2026)Nadia Hindi · Comunidad de Madrid4 papers (2017–2020)